Table of Contents
1 Gene Therapy in Oncology Market Overview
1.1 Product Overview and Scope of Gene Therapy in Oncology
1.2 Classification of Gene Therapy in Oncology by Types
1.2.1 Global Gene Therapy in Oncology Revenue Comparison by Types (2019-2024)
1.2.2 Global Gene Therapy in Oncology Revenue Market Share by Types in 2018
1.2.3 Ex Vivo
1.2.4 In Vivo
1.3 Global Gene Therapy in Oncology Market by Application
1.3.1 Global Gene Therapy in Oncology Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Global Gene Therapy in Oncology Market by Regions
1.4.1 Global Gene Therapy in Oncology Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Gene Therapy in Oncology Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapy in Oncology Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapy in Oncology Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapy in Oncology Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapy in Oncology Status and Prospect (2014-2024)
1.5 Global Market Size of Gene Therapy in Oncology (2014-2024)
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 Gene Therapy in Oncology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.2 Cold Genesys
2.2.1 Business Overview
2.2.2 Gene Therapy in Oncology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.3 Advantagene
2.3.1 Business Overview
2.3.2 Gene Therapy in Oncology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Gene Therapy in Oncology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Gene Therapy in Oncology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bio-Path Holdings
2.6.1 Business Overview
2.6.2 Gene Therapy in Oncology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.7 CRISPR Therapeutics
2.7.1 Business Overview
2.7.2 Gene Therapy in Oncology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.8 Editas Medicine
2.8.1 Business Overview
2.8.2 Gene Therapy in Oncology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.9 Geron Corp
2.9.1 Business Overview
2.9.2 Gene Therapy in Oncology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.10 Idera Pharmaceuticals
2.10.1 Business Overview
2.10.2 Gene Therapy in Oncology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.11 Intellia Therapeutics
2.11.1 Business Overview
2.11.2 Gene Therapy in Oncology Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.12 Johnson & Johnson
2.12.1 Business Overview
2.12.2 Gene Therapy in Oncology Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.13 Marsala Biotech
2.13.1 Business Overview
2.13.2 Gene Therapy in Oncology Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.14 Merck
2.14.1 Business Overview
2.14.2 Gene Therapy in Oncology Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.15 Mologen AG
2.15.1 Business Overview
2.15.2 Gene Therapy in Oncology Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.16 Oncolytics Biotech
2.16.1 Business Overview
2.16.2 Gene Therapy in Oncology Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.17 Oncosec
2.17.1 Business Overview
2.17.2 Gene Therapy in Oncology Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.18 Oncotelic
2.18.1 Business Overview
2.18.2 Gene Therapy in Oncology Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.19 Shenzhen SiBiono GeneTech
2.19.1 Business Overview
2.19.2 Gene Therapy in Oncology Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.20 Sillajen Biotherapeutics
2.20.1 Business Overview
2.20.2 Gene Therapy in Oncology Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.21 Tocagen
2.21.1 Business Overview
2.2.2 Gene Therapy in Oncology Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.22 UniQure
2.22.1 Business Overview
2.22.2 Gene Therapy in Oncology Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
2.23 Ziopharm Oncology
2.23.1 Business Overview
2.23.2 Gene Therapy in Oncology Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
3 Global Gene Therapy in Oncology Market Competition, by Players
3.1 Global Gene Therapy in Oncology Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Gene Therapy in Oncology Players Market Share
3.2.2 Top 10 Gene Therapy in Oncology Players Market Share
3.3 Market Competition Trend
4 Global Gene Therapy in Oncology Market Size by Regions
4.1 Global Gene Therapy in Oncology Revenue and Market Share by Regions
4.2 North America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
4.3 Europe Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
4.5 South America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
5 North America Gene Therapy in Oncology Revenue by Countries
5.1 North America Gene Therapy in Oncology Revenue by Countries (2014-2019)
5.2 USA Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
5.3 Canada Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
5.4 Mexico Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
6 Europe Gene Therapy in Oncology Revenue by Countries
6.1 Europe Gene Therapy in Oncology Revenue by Countries (2014-2019)
6.2 Germany Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
6.3 UK Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
6.4 France Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
6.5 Russia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
6.6 Italy Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Gene Therapy in Oncology Revenue by Countries
7.1 Asia-Pacific Gene Therapy in Oncology Revenue by Countries (2014-2019)
7.2 China Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
7.3 Japan Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
7.4 Korea Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
7.5 India Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
8 South America Gene Therapy in Oncology Revenue by Countries
8.1 South America Gene Therapy in Oncology Revenue by Countries (2014-2019)
8.2 Brazil Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
8.3 Argentina Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
8.4 Colombia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Gene Therapy in Oncology by Countries
9.1 Middle East and Africa Gene Therapy in Oncology Revenue by Countries (2014-2019)
9.2 Saudi Arabia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
9.3 UAE Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
9.4 Egypt Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
9.5 Nigeria Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
9.6 South Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
10 Global Gene Therapy in Oncology Market Segment by Type
10.1 Global Gene Therapy in Oncology Revenue and Market Share by Type (2014-2019)
10.2 Global Gene Therapy in Oncology Market Forecast by Type (2019-2024)
10.3 Ex Vivo Revenue Growth Rate (2014-2024)
10.4 In Vivo Revenue Growth Rate (2014-2024)
11 Global Gene Therapy in Oncology Market Segment by Application
11.1 Global Gene Therapy in Oncology Revenue Market Share by Application (2014-2019)
11.2 Gene Therapy in Oncology Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Diagnostics Centers Revenue Growth (2014-2019)
11.5 Research Institutes Revenue Growth (2014-2019)
12 Global Gene Therapy in Oncology Market Size Forecast (2019-2024)
12.1 Global Gene Therapy in Oncology Market Size Forecast (2019-2024)
12.2 Global Gene Therapy in Oncology Market Forecast by Regions (2019-2024)
12.3 North America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
12.4 Europe Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
12.6 South America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Gene Therapy in Oncology Picture
Table Product Specifications of Gene Therapy in Oncology
Table Global Gene Therapy in Oncology and Revenue (Million USD) Market Split by Product Type
Figure Global Gene Therapy in Oncology Revenue Market Share by Types in 2018
Figure Ex Vivo Picture
Figure In Vivo Picture
Table Global Gene Therapy in Oncology Revenue (Million USD) by Application (2014-2024)
Figure Gene Therapy in Oncology Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Diagnostics Centers Picture
Figure Research Institutes Picture
Table Global Market Gene Therapy in Oncology Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Gene Therapy in Oncology Type and Applications
Table Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Cold Genesys Basic Information, Manufacturing Base and Competitors
Table Cold Genesys Gene Therapy in Oncology Type and Applications
Table Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Advantagene Basic Information, Manufacturing Base and Competitors
Table Advantagene Gene Therapy in Oncology Type and Applications
Table Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Gene Therapy in Oncology Type and Applications
Table Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gene Therapy in Oncology Type and Applications
Table AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Bio-Path Holdings Basic Information, Manufacturing Base and Competitors
Table Bio-Path Holdings Gene Therapy in Oncology Type and Applications
Table Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table CRISPR Therapeutics Gene Therapy in Oncology Type and Applications
Table CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Editas Medicine Basic Information, Manufacturing Base and Competitors
Table Editas Medicine Gene Therapy in Oncology Type and Applications
Table Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Geron Corp Basic Information, Manufacturing Base and Competitors
Table Geron Corp Gene Therapy in Oncology Type and Applications
Table Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Idera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Idera Pharmaceuticals Gene Therapy in Oncology Type and Applications
Table Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Intellia Therapeutics Basic Information, Manufacturing Base and Competitors
Table Intellia Therapeutics Gene Therapy in Oncology Type and Applications
Table Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Gene Therapy in Oncology Type and Applications
Table Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Marsala Biotech Basic Information, Manufacturing Base and Competitors
Table Marsala Biotech Gene Therapy in Oncology Type and Applications
Table Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Gene Therapy in Oncology Type and Applications
Table Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Mologen AG Basic Information, Manufacturing Base and Competitors
Table Mologen AG Gene Therapy in Oncology Type and Applications
Table Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Oncolytics Biotech Basic Information, Manufacturing Base and Competitors
Table Oncolytics Biotech Gene Therapy in Oncology Type and Applications
Table Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Oncosec Basic Information, Manufacturing Base and Competitors
Table Oncosec Gene Therapy in Oncology Type and Applications
Table Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Oncotelic Basic Information, Manufacturing Base and Competitors
Table Oncotelic Gene Therapy in Oncology Type and Applications
Table Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Shenzhen SiBiono GeneTech Basic Information, Manufacturing Base and Competitors
Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Type and Applications
Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Sillajen Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table Sillajen Biotherapeutics Gene Therapy in Oncology Type and Applications
Table Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Tocagen Basic Information, Manufacturing Base and Competitors
Table Tocagen Gene Therapy in Oncology Type and Applications
Table Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table UniQure Basic Information, Manufacturing Base and Competitors
Table UniQure Gene Therapy in Oncology Type and Applications
Table UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Ziopharm Oncology Basic Information, Manufacturing Base and Competitors
Table Ziopharm Oncology Gene Therapy in Oncology Type and Applications
Table Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)
Table Global Gene Therapy in Oncology Revenue (Million USD) by Players (2014-2019)
Table Global Gene Therapy in Oncology Revenue Share by Players (2014-2019)
Figure Global Gene Therapy in Oncology Revenue Share by Players in 2017
Figure Global Gene Therapy in Oncology Revenue Share by Players in 2018
Figure Global Top 5 Players Gene Therapy in Oncology Revenue Market Share in 2018
Figure Global Top 10 Players Gene Therapy in Oncology Revenue Market Share in 2018
Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Gene Therapy in Oncology Revenue (Million USD) by Regions (2014-2019)
Table Global Gene Therapy in Oncology Revenue Market Share by Regions (2014-2019)
Figure Global Gene Therapy in Oncology Revenue Market Share by Regions (2014-2019)
Figure Global Gene Therapy in Oncology Revenue Market Share by Regions in 2018
Figure North America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Europe Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure South America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Table North America Gene Therapy in Oncology Revenue by Countries (2014-2019)
Table North America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)
Figure North America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)
Figure North America Gene Therapy in Oncology Revenue Market Share by Countries in 2018
Figure USA Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Canada Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Mexico Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Table Europe Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)
Figure Europe Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)
Figure Europe Gene Therapy in Oncology Revenue Market Share by Countries in 2018
Figure Germany Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure UK Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure France Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Russia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Italy Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Countries in 2018
Figure China Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Japan Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Korea Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure India Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Table South America Gene Therapy in Oncology Revenue by Countries (2014-2019)
Table South America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)
Figure South America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)
Figure South America Gene Therapy in Oncology Revenue Market Share by Countries in 2018
Figure Brazil Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Argentina Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Colombia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries in 2018
Figure Saudi Arabia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure UAE Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Egypt Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure Nigeria Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Figure South Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)
Table Global Gene Therapy in Oncology Revenue (Million USD) by Type (2014-2019)
Table Global Gene Therapy in Oncology Revenue Share by Type (2014-2019)
Figure Global Gene Therapy in Oncology Revenue Share by Type (2014-2019)
Figure Global Gene Therapy in Oncology Revenue Share by Type in 2019
Table Global Gene Therapy in Oncology Revenue Forecast by Type (2019-2024)
Figure Global Gene Therapy in Oncology Market Share Forecast by Type (2019-2024)
Figure Global Ex Vivo Revenue Growth Rate (2014-2019)
Figure Global In Vivo Revenue Growth Rate (2014-2019)
Table Global Gene Therapy in Oncology Revenue by Application (2014-2019)
Table Global Gene Therapy in Oncology Revenue Share by Application (2014-2019)
Figure Global Gene Therapy in Oncology Revenue Share by Application (2014-2019)
Figure Global Gene Therapy in Oncology Revenue Share by Application in 2019
Table Global Gene Therapy in Oncology Revenue Forecast by Application (2019-2024)
Figure Global Gene Therapy in Oncology Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Diagnostics Centers Revenue Growth Rate (2014-2019)
Figure Global Research Institutes Revenue Growth Rate (2014-2019)
Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Gene Therapy in Oncology Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Gene Therapy in Oncology Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
Figure Europe Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
Figure South America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Forecast (2019-2024)
【掲載企業】
Bristol-Myers Squibb、Cold Genesys、Advantagene、Amgen、AstraZeneca、Bio-Path Holdings、CRISPR Therapeutics、Editas Medicine、Geron Corp、Idera Pharmaceuticals、Intellia Therapeutics、Johnson & Johnson、Marsala Biotech、Merck、Mologen AG、Oncolytics Biotech、Oncosec、Oncotelic、Shenzhen SiBiono GeneTech、Sillajen Biotherapeutics、Tocagen、UniQure、Ziopharm Oncology、
